 | This article needs to be updated. The reason given is: Results of the investigation and further implications in 2021 and into 2022.. (May 2022) |
 | |
| Native name | Caso Covaxin |
|---|---|
| Date | June 16, 2021 |
| Time | (UTC−3) |
| Duration | 3 years, 5 months and 6 days |
| Location | Brazil |
| Also known as | Covaxgate |
| Type | Alleged overbilling of 20 million doses of Covaxin vaccine by members of the Brazilian government |
The Case Covaxin,[1] also known as Covaxgate,[2] refers to an investigation made by the Brazilian Federal Public Ministry (MPF), held on June 16, 2021,[3] which found evidence of irregularities in the purchase of 20 million doses by the Ministry of Health of the Indian vaccine Covaxin, with the value of the vaccines 1000% higher than initially foreseen.[4]
The Prosecutor General of the Republic has also asked to investigate whether President Jair Bolsonaro committed the crime of misfeasance, for allegedly failing to report to investigative bodies evidence of corruption in the negotiations to purchase the vaccine.[5]
- ^ "Caso Covaxin: Senadora aponta falsificação em documento usado pelo governo Bolsonaro" (in Brazilian Portuguese). 2021-07-06. Retrieved 2021-07-08.
- ^ "Randolfe promete novos documentos para provar a corrupção do Covaxgate" (in Brazilian Portuguese). 2021-06-28. Retrieved 2021-07-08.
- ^ Caroline Oliveira (2021-06-29). "Caso Covaxin: o que se sabe até agora?" (in Brazilian Portuguese). Retrieved 2021-07-08.
- ^ Rachel Vargas; Gustavo Uribe (2021-06-22). "Documentos apontam que governo comprou vacina indiana por valor 1000% maior". Retrieved 2021-07-08.
- ^ "PGR pede investigação sobre prevaricação de Bolsonaro na compra da Covaxin" (in Brazilian Portuguese). 2021-07-02. Retrieved 2021-07-08.